Sun Pharmaceutical Industries Ltd. shares reached a record high of ₹1,966.30 on July 27, 2026.
The stock climbed 1.30% during the session, outperforming the Sensex’s 0.86% rise. Share value has increased 73.23% over the last three years.
Trading volume exceeded 30 lakh shares, resulting in a turnover of more than ₹603 crores. High trading activity indicates significant institutional interest and investor confidence in the company.
The stock currently trades at a P/E ratio of 37x. This multiple represents a premium over industry averages, suggesting future earnings growth may already be priced in.